High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker (Q34126942)

31 July 2017

High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker (English)

1 reference

invasive ductal carcinoma

31 July 2017

1 reference

1 reference

based on heuristic

inferred from title

pancreatic ductal adenocarcinoma

1 reference

based on heuristic

inferred from title

pancreatic ductal carcinoma

1 reference

9

Toshiaki Shichinohe

1 reference

31 July 2017

Kei Hiraoka

1

1 reference

31 July 2017

Yasuhiro Hida

2

1 reference

31 July 2017

Masaki Miyamoto

3

1 reference

31 July 2017

Taro Oshikiri

4

1 reference

31 July 2017

Masato Suzuoki

5

1 reference

31 July 2017

Yoshihiro Nakakubo

6

1 reference

31 July 2017

Toshiya Shinohara

7

1 reference

31 July 2017

Tomoo Itoh

8

1 reference

31 July 2017

Satoshi Kondo

10

1 reference

31 July 2017

Noriyuki Kasahara

11

1 reference

31 July 2017

Hiroyuki Katoh

12

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Cancer

31 July 2017

1 reference

31 July 2017

99

1 reference

31 July 2017

3

1 reference

31 July 2017

418-423

1 reference

The National Cancer Data Base report on pancreatic cancer

31 July 2017

1 reference

Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database.

21 January 2018

1 reference

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

21 January 2018

1 reference

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

21 January 2018

1 reference

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors

21 January 2018

1 reference

KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas

21 January 2018

1 reference

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation

21 January 2018

1 reference

A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas

21 January 2018

1 reference

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

21 January 2018

1 reference

Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigens

21 January 2018

1 reference

Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma

21 January 2018

1 reference

Histocompatibility antigens on murine tumors

21 January 2018

1 reference

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

Relation of pancreatic duct hyperplasia to carcinoma

21 January 2018

1 reference

Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.

21 January 2018

1 reference

The dominant negative H-ras mutant, N116Y, suppresses growth of metastatic human pancreatic cancer cells in the liver of nude mice

21 January 2018

1 reference

Japan Pancreatic Cancer Registry: current status.

21 January 2018

1 reference

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial

21 January 2018

1 reference

Ki-ras oncogene activation in preinvasive pancreatic cancer

21 January 2018

1 reference

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

21 January 2018

1 reference

High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

21 January 2018

1 reference

Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1

21 January 2018

1 reference

Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma

21 January 2018

1 reference

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

21 January 2018

1 reference

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

21 January 2018

1 reference

The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium

21 January 2018

1 reference

Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10381

1 reference

31 July 2017

1 reference